These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 24100214)

  • 1. Renal sympathetic nerve ablation for the management of resistant hypertension: an update.
    Thorp AA; Larsen RN; Schlaich MP
    Curr Opin Nephrol Hypertens; 2013 Nov; 22(6):607-14. PubMed ID: 24100214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal denervation therapy for the treatment of resistant hypertension: a position statement by the Canadian Hypertension Education Program.
    Khan NA; Herman RJ; Quinn RR; Rabkin SW; Ravani P; Tobe SW; Feldman RD; Wijeysundera HC; Padwal RS;
    Can J Cardiol; 2014 Jan; 30(1):16-21. PubMed ID: 24269056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal sympathetic denervation in hypertension.
    Doumas M; Faselis C; Papademetriou V
    Curr Opin Nephrol Hypertens; 2011 Nov; 20(6):647-53. PubMed ID: 21885968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal denervation: current implications and future perspectives.
    Xu J; Hering D; Sata Y; Walton A; Krum H; Esler MD; Schlaich MP
    Clin Sci (Lond); 2014 Jan; 126(1):41-53. PubMed ID: 24020446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catheter-based renal sympathetic denervation: limitations to and gaps in the evidence.
    Hiremath S; Froeschl M; Ruzicka M
    Curr Opin Cardiol; 2014 Jul; 29(4):336-43. PubMed ID: 24859619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catheter-based renal denervation for drug-resistant hypertension by using a standard electrophysiology catheter.
    Prochnau D; Lucas N; Kuehnert H; Figulla HR; Surber R
    EuroIntervention; 2012 Jan; 7(9):1077-80. PubMed ID: 21959556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent developments in renal denervation.
    Raphael CE; Davies JE
    Minerva Cardioangiol; 2013 Jun; 61(3):271-80. PubMed ID: 23681130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal sympathetic denervation and systemic hypertension.
    Doumas M; Faselis C; Papademetriou V
    Am J Cardiol; 2010 Feb; 105(4):570-6. PubMed ID: 20152255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous renal sympathetic denervation: 2013 and beyond.
    Froeschl M; Hadziomerovic A; Ruzicka M
    Can J Cardiol; 2014 Jan; 30(1):64-74. PubMed ID: 24365191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catheter-based radiofrequency renal-nerve ablation in patients with resistant hypertension.
    Azizi M; Steichen O; Frank M; Bobrie G; Plouin PF; Sapoval M
    Eur J Vasc Endovasc Surg; 2012 Mar; 43(3):293-9. PubMed ID: 22237510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catheter-based renal denervation for treatment of resistant hypertension.
    Vase H; Mathiassen ON; Kaltoft A; Pedersen EB; Christensen KL; Buus NH; Lederballe O; Lassen JF; Bøtker HE; Thuesen L
    Dan Med J; 2012 Jun; 59(6):A4439. PubMed ID: 22677237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal denervation in treatment-resistant hypertension: the need for restraint and more and better evidence.
    Persu A; Renkin J; Asayama K; O'Brien E; Staessen JA
    Expert Rev Cardiovasc Ther; 2013 Jun; 11(6):739-49. PubMed ID: 23750683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility of catheter-based renal nerve ablation and effects on sympathetic nerve activity and blood pressure in patients with end-stage renal disease.
    Schlaich MP; Bart B; Hering D; Walton A; Marusic P; Mahfoud F; Böhm M; Lambert EA; Krum H; Sobotka PA; Schmieder RE; Ika-Sari C; Eikelis N; Straznicky N; Lambert GW; Esler MD
    Int J Cardiol; 2013 Oct; 168(3):2214-20. PubMed ID: 23453868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Renal denervation: current state and future perspectives].
    Kara K; Bruck H; Kahlert P; Plicht B; Mahabadi AA; Konorza T; Erbel R
    Herz; 2012 Nov; 37(7):746-53. PubMed ID: 23073661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal Denervation After SYMPLICITY HTN-3: Where Do We Go?
    Briasoulis A; Bakris G
    Can J Cardiol; 2015 May; 31(5):642-8. PubMed ID: 25828371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal denervation and hypertension.
    Schlaich MP; Krum H; Sobotka PA; Esler MD
    Am J Hypertens; 2011 Jun; 24(6):635-42. PubMed ID: 21394087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expanding the indication spectrum: renal denervation in diabetes.
    Mahfoud F; Ewen S; Ukena C; Linz D; Sobotka PA; Cremers B; Böhm M
    EuroIntervention; 2013 May; 9 Suppl R():R117-21. PubMed ID: 23732142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal nerve ablation for resistant hypertension: how did we get here, present status, and future directions.
    Papademetriou V; Rashidi AA; Tsioufis C; Doumas M
    Circulation; 2014 Apr; 129(13):1440-51. PubMed ID: 24687645
    [No Abstract]   [Full Text] [Related]  

  • 19. Renal denervation in the management of resistant hypertension: current evidence and perspectives.
    Jin Y; Persu A; Staessen JA
    Curr Opin Nephrol Hypertens; 2013 Sep; 22(5):511-8. PubMed ID: 23892701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal sympathetic denervation as second-line therapy in mild resistant hypertension: a pilot study.
    Kaltenbach B; Franke J; Bertog SC; Steinberg DH; Hofmann I; Sievert H
    Catheter Cardiovasc Interv; 2013 Feb; 81(2):335-9. PubMed ID: 22807098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.